Market Report Source

Overview

Introduction

EPIX Pharmaceuticals is a clinical-stage biopharmaceutical company focused on small molecule drug discovery and development with pipeline of internally-discovered drug candidates currently in clinical development to treat diseases of the central nervous system and lung conditions. The company’s lead product, Vasovist is marketed in 32 European nation and waiting for the approval in US.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

EPIX Pharmaceuticals’ proprietary development program integrates computational methods with the medical chemistry which addresses the inefficiencies associated with the traditional methods of drug discovery.The company has four therapeutic product candidates in clinical trials for depression, Alzheimer’s disease, cardiovascular disease and obesity. EPIX Pharmaceuticals derives its revenues from royalties, license and collaboration fees. The company’s total revenues decreased from $12 million in 2004 to $4 million in 2006. EPIX Pharmaceuticals’ total revenues are forecasted to expand by a CAGR of 66% over the period 2006-2010. The growth is attributed to the royalties, license, collaboration, and others, anticipating the company’s business development deals and clinical developments of its early stage drug candidates.

Reasons to Purchase

Access all the important information and analysis on the company in a single report Understand company’s strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company’s adjusted five year financial data along with key ratios and market capitalization.

Table of Contents

Overview
Catalyst
Summary
Company Structure
Company Overview and Key Facts
Business Description
History
Locations and Subsidiaries
Company Financials
Stock Market Performance
P&L
Balance Sheet
Cash Flow
Business Segment Performance
Business Segment Performance
Products & Services
Pipeline Products
AC Forecast Product Sales
Competitors and Strategic Business Relationships
Key Competitors
Key Suppliers
Key Clients
Shareholding Structure
Strategy
Company View
Corporate Strategy
SWOT Analysis
Overview
Strengths
Weaknesses
Opportunities
Threats
Value Chain Analysis
Overview
Discovery and Product Development
Scorecard
Overview
Scorecard Analysis
Key Employees
List of Key Employees
Key Employee Biographies
Financial and Operational Overview
Financial and Operational Overview

APPENDIX
Ask the analyst
Datamonitor consulting
Disclaimer

FIGURES
Figure 1: EPIX Pharmaceutical – Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
Figure 2: EPIX Pharmaceuticals – Key Strategic Revenues, 2002-2006 ($ Mn)
Figure 3: EPIX Pharmaceuticals – Key Strategic Revenues, 2006-2010 ($ Mn)

TABLES
Table 1: EPIX Pharmaceuticals – Key Facts
Table 2: EPIX Pharmaceuticals – Other Locations and Subsidiaries
Table 3: EPIX Pharmaceuticals – Year-End Share Price and Market Capitalization, 2002-2006 ($)
Table 4: EPIX Pharmaceuticals – Key Events Impacting Share Price Performance
Table 5: EPIX Pharmaceuticals – Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
Table 6: EPIX Pharmaceuticals – Operating Cost Ratio Analysis, 2002-2006 (% of total revenues)
Table 7: EPIX Pharmaceuticals – Balance Sheet, 2002-2006 ($ Mn)
Table 8: EPIX Pharmaceuticals – Cash Flow, 2002-2006 ($ Mn)
Table 9: EPIX Pharmaceuticals – Revenue Breakdown by Division, 2002-2006 ($ Mn)
Table 10: EPIX Pharmaceuticals – In-house Pipeline Products
Table 11: EPIX Pharmaceuticals – Collaboration Pipeline Products
Table 12: EPIX Pharmaceuticals – Forecast Sales, 2006-2010 ($ Mn)
Table 13: EPIX Pharmaceuticals – Key Competitors
Table 14: EPIX Pharmaceuticals – Key Suppliers
Table 15: EPIX Pharmaceuticals – Key Suppliers
Table 16: EPIX Pharmaceuticals – Key Shareholders
Table 17: EPIX Pharmaceuticals – SWOT Analysis Summary
Table 18: EPIX Pharmaceuticals – Value Chain Analysis
Table 19: EPIX Pharmaceuticals – Scorecard
Table 20: EPIX Pharmaceuticals – Key Employees
Table 21: EPIX Pharmaceuticals – Financial and Operational Overview